Product Name:[(1-Benzyl-1H-pyrazol-4-yl)methyl]amine
IUPAC Name:1-(1-benzyl-1H-pyrazol-4-yl)methanamine
Product Overview |
(1-benzyl-1H-pyrazol-4-yl)methanamine, also known as Benzylpyrazolamine or BZP, is a synthetic compound that has been studied for its potential applications in scientific research. BZP is a derivative of pyrazolamine, a heterocyclic compound. It has been studied for its potential applications in drug design, drug delivery, and other areas of scientific research. |
Synthesis Method |
BZP can be synthesized by reacting 4-amino-1-benzyl-1H-pyrazole with formaldehyde in the presence of an acid catalyst such as hydrochloric acid. The reaction produces a mixture of BZP and the corresponding 4-amino-1-benzyl-1H-pyrazole-formaldehyde adduct. |
Scientific Research Applications |
BZP has been studied for its potential applications in drug design and drug delivery, as it has been shown to be a potent inhibitor of cytochrome P450 enzymes. It has also been studied for its potential applications in the treatment of neurological disorders, such as Alzheimer’s disease and Parkinson’s disease. Additionally, BZP has been studied for its potential applications in cancer research, as it has been found to inhibit the growth of certain types of cancer cells. |
Future Directions |
These include further studies of its potential applications in drug design and delivery, as well as its potential applications in the treatment of neurological disorders and cancer. Additionally, further studies of its biochemical and physiological effects may provide insight into its potential therapeutic uses. Finally, further studies of its stability and storage requirements may allow for its use in a wider range of laboratory experiments. |
Storage and Handling |
It is relatively stable and can be stored for long periods of time. |